Kalvista Price Sales Ratio from 2010 to 2025

KALV Stock  USD 12.50  0.25  2.04%   
Kalvista Pharmaceuticals Price Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price Sales Ratio will likely drop to 46.33 in 2025. During the period from 2010 to 2025, Kalvista Pharmaceuticals Price Sales Ratio regression line of quarterly data had mean square error of  898.02 and geometric mean of  35.77. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
58.07
Current Value
46.33
Quarterly Volatility
28.97809753
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 985.3 K, Interest Expense of 0.0 or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 46.33, Dividend Yield of 0.0 or Days Sales Outstanding of 268. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Kalvista Pharmaceuticals Correlation against competitors.
For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.

Latest Kalvista Pharmaceuticals' Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Kalvista Pharmaceuticals over the last few years. It is Kalvista Pharmaceuticals' Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Very volatile
   Price Sales Ratio   
       Timeline  

Kalvista Price Sales Ratio Regression Statistics

Arithmetic Mean42.55
Geometric Mean35.77
Coefficient Of Variation68.11
Mean Deviation18.60
Median46.33
Standard Deviation28.98
Sample Variance839.73
Range124
R-Value0.04
Mean Square Error898.02
R-Squared0
Significance0.87
Slope0.26
Total Sum of Squares12,596

Kalvista Price Sales Ratio History

2025 46.33
2024 58.07
2020 37.57
2019 15.26
2018 21.51
2017 11.83
2016 46.82

About Kalvista Pharmaceuticals Financial Statements

Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Price Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Sales Ratio 58.07  46.33 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Kalvista Stock Analysis

When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.